In the future, we will consider designing our study to document more confounding factors, including ALT and AST fluctuations, cytolytic activity, NAFLD, viral hepatitis, alcohol abuse, and use of drugs during follow-up. This evidence concerns the gene GPT and animal viral hepatitis.